The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids

December 24, 2013 updated by: Woo Seog Sim, Samsung Medical Center
There has been no reports of the effect of various kinds of steroid or various dose of steroid which are commonly used in the clinical setting. Previous studies have simply shown that the blood glucose level is elevated in diabetes patients and did not show or suggest the adequate strategy of epidural steroid injection in diabetes patients regarding steroid type, dosage or injection interval. Therefore, the investigators tried to evaluate the effect of different dosage of triamcinolone, which is a commonly used steroid in epidural steroid injection, on the blood glucose level.

Study Overview

Detailed Description

It is well known that blood glucose level is elevated in diabetes patients more than non-diabetes patients who underwent the epidural steroid injection. However, there has been no reports of the effect of various kinds of steroid or various dose of steroid which are commonly used in the clinical setting. Previous studies have simply shown that the blood glucose level is elevated in diabetes patients and did not show or suggest the adequate strategy of epidural steroid injection in diabetes patients regarding steroid type, dosage or injection interval. Therefore, the investigators tried to evaluate the effect of different dosage of triamcinolone, which is a commonly used steroid in epidural steroid injection, on the blood glucose level.

Study Type

Interventional

Enrollment (Actual)

125

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • subjects who undergo epidural steroid injection (caudal epidural injection or selective transforaminal block) in the pain medicine outpatient clinic
  • subjects older than 20 yrs.

Exclusion Criteria:

  • ASA (American society of Anesthesiologists class) III or more
  • severe cardiopulmonary disease or brain disorder
  • Subjects diagnosed uncontrolled diabetes with complications
  • subjects undergoing hormone therapy
  • subjects with active infection
  • subjects with pregnancy
  • subjects with recent stress condition such as surgery or trauma
  • subjects with active neurologic disorder
  • those with anticoagulation therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Caudal 40 group
subjects who undergo caudal epidural block with triamcinolone 40 mg
epidural steroid injection with Triamcinolone 40mg
Other Names:
  • Triamcinolone
  • epidural steroid injection
  • caudal epidural block
Experimental: STE 20 group
subjects who undergo selective transforaminal block with triamcinolone 20 mg
Selective transforaminal epidural block with triamcinolone 20 mg
Other Names:
  • Triamcinolone
  • epidural steroid injection
  • selective transforaminal block
Experimental: Caudal 20 mg
subjects who undergo caudal epidural block with triamcinolone 20 mg
caudal epidural steroid injection with Triamcinolone 20mg
Other Names:
  • Triamcinolone
  • epidural steroid injection
  • caudal epidural block
Experimental: STE 40 group
subjects who undergo selective transforaminal block with triamcinolone 40 mg
Selective transforaminal epidural block with triamcinolone 40 mg
Other Names:
  • Triamcinolone
  • epidural steroid injection
  • selective transforaminal block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 1
before breakfast (fasting state)
at 7:00 am of postprocedure day 1
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 2
before breakfast (fasting state)
at 7:00 am of postprocedure day 2
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 3
at 7:00 am of postprocedure day 3
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 4
at 7:00 am of postprocedure day 4
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 5
at 7:00 am of postprocedure day 5
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 6
at 7:00 am of postprocedure day 6
fasting blood glucose level
Time Frame: at 7:00 am of postprocedure day 7
at 7:00 am of postprocedure day 7
fasting blood glucose
Time Frame: at 7:00 am of postprocedure day 14
at 7:00 am of postprocedure day 14

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post-prandial glucose level
Time Frame: 2 hour after dinner at postprandial day 1, 2, 3, 4, 5, 6, 7, 14
2 hour after dinner
2 hour after dinner at postprandial day 1, 2, 3, 4, 5, 6, 7, 14
visual analogue scale of subjective pain
Time Frame: at 7 p.m. of postprocedure day 1, 2, 3, 4, 5, 6, 7, 14
at 7:00 am of postprocedure day 5
at 7 p.m. of postprocedure day 1, 2, 3, 4, 5, 6, 7, 14

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2011

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

March 1, 2013

Study Registration Dates

First Submitted

September 15, 2011

First Submitted That Met QC Criteria

September 16, 2011

First Posted (Estimate)

September 19, 2011

Study Record Updates

Last Update Posted (Estimate)

December 25, 2013

Last Update Submitted That Met QC Criteria

December 24, 2013

Last Verified

December 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on epidural steroid injection with Triamcinolone 40mg

Subscribe